UKHSA is considering options for Surge Laboratory Capacity to ensure rapid response during public health emergencies, focusing on rapidly scaling up PCR testing capabilities for Pathogen X. Please note, the indicative contract value below is for a cold state running of the contract and a hot state contract value will be many multiples more
Just look at the SP in relation to assets and future growth, that’s not including cash in bank, some big Pharmaceutical company will swallow this up just based on Probability